172 related articles for article (PubMed ID: 38515057)
1. Clinical significance of low expression of CADM3 in breast cancer and preliminary exploration of related mechanisms.
Ren H; Wang Z; Zhang L; Zhu G; Li F; Chen B
BMC Cancer; 2024 Mar; 24(1):367. PubMed ID: 38515057
[TBL] [Abstract][Full Text] [Related]
2. miR-140-5p suppresses retinoblastoma cell proliferation, migration, and invasion by targeting CEMIP and CADM3.
Miao X; Wang Z; Chen B; Chen Y; Wang X; Jiang L; Jiang S; Hao K; Zhang W
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):42-47. PubMed ID: 29808799
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
[TBL] [Abstract][Full Text] [Related]
5. Differential Contribution of Cadm1-Cadm3 Cell Adhesion Molecules to Peripheral Myelinated Axons.
Sukhanov N; Vainshtein A; Eshed-Eisenbach Y; Peles E
J Neurosci; 2021 Feb; 41(7):1393-1400. PubMed ID: 33397712
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract][Full Text] [Related]
7. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.
Zhao W; Chang Y; Wu Z; Jiang X; Li Y; Xie R; Fu D; Sun C; Gao J
PeerJ; 2023; 11():e15703. PubMed ID: 37483962
[TBL] [Abstract][Full Text] [Related]
8. Cadm3 (Necl-1) interferes with the activation of the PI3 kinase/Akt signaling cascade and inhibits Schwann cell myelination in vitro.
Chen MS; Kim H; Jagot-Lacoussiere L; Maurel P
Glia; 2016 Dec; 64(12):2247-2262. PubMed ID: 27658374
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circPRMT5 is upregulated in breast cancer and is required for cell proliferation and migration.
Li X; Zhang D; Feng Z; Xu X; Zhang J; Yu A; Zhu L; Xiao J; Du J; Chen M
Turk J Med Sci; 2022 Apr; 52(2):303-312. PubMed ID: 36161608
[TBL] [Abstract][Full Text] [Related]
10. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
11. A CADM3 variant causes Charcot-Marie-Tooth disease with marked upper limb involvement.
Rebelo AP; Cortese A; Abraham A; Eshed-Eisenbach Y; Shner G; Vainshtein A; Buglo E; Camarena V; Gaidosh G; Shiekhattar R; Abreu L; Courel S; Burns DK; Bai Y; Bacon C; Feely SME; Castro D; Peles E; Reilly MM; Shy ME; Zuchner S
Brain; 2021 May; 144(4):1197-1213. PubMed ID: 33889941
[TBL] [Abstract][Full Text] [Related]
12. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane protein 92 performs a tumor-promoting function in breast carcinoma by contributing to the cell growth, invasion, migration and epithelial-mesenchymal transition.
Lin MZ; Teng LL; Sun XL; Zhang LP; Chen F; Yu LJ
Tissue Cell; 2020 Dec; 67():101415. PubMed ID: 32835947
[TBL] [Abstract][Full Text] [Related]
14. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
15. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
17. High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.
Gatti G; Betts C; Rocha D; Nicola M; Grupe V; Ditada C; Nuñez NG; Roselli E; Araya P; Dutto J; Boffelli L; Fernández E; Coussens LM; Maccioni M
Breast Cancer Res; 2021 Mar; 23(1):40. PubMed ID: 33766090
[TBL] [Abstract][Full Text] [Related]
18. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract][Full Text] [Related]
20. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]